Hello,I’m Shira Orr, the Founder and CEO of Envoya Inc. I am dedicated to advancing gene therapy through innovative delivery technologies specifically tailored to treat genetic disorders. My journey into this field is driven by a personal mission—having witnessed my family members struggle with a genetic disorder. This profound personal connection fuels my commitment to drive gene delivery technologies forward.With a PhD in Biotechnology Engineering and postdoctoral training from Harvard Medical School, my expertise spans polymer science and Immunology. I leverage this knowledge to create delivery solutions that are both effective and personalized. At Envoya, we strive to transcend conventional treatments by engineering targeted gene therapy delivery systems.Recognizing the uniqueness of each genetic condition, my approach involves a detailed understanding of individual cases to deliver gene therapy that not only aims to cure but also significantly improve the quality of life. This mission is deeply personal to me. Join us as we unlock the potential of gene therapy, making meaningful strides toward a healthier world.Feel free to connect with me on LinkedIn to explore the potential and promise of modern gene therapy delivery.You can also Book a consultation call with me. 📞https://meetings.hubspot.com/shira-orr?uuid=2c03e645-3e12-4f58-9350-98971911e29c Visit our website to learn more about our innovative approaches and how Envoya's groundbreaking technologies can revolutionize treatment for genetic disorders, offering new hope and practical solutions to those in need. 🌐https://www.envoyabio.com/